Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 17 Source: CRO
- €72.7 million turnover
-
€37,763
profit
-
31st Dec 16 Source: CRO
- €98.3 million turnover
-
€44,242
profit
- 6 more years available »
Ranking
By Turnover
(€72.7 million)- 568th in Top Companies
- 58th in Pharma
-
- €72.7 million
Employees
- David Cadogan Director
Latest News
- 10:54am SMBC Aviation Capital appoints Tomoyuki Tanaka as chairman
- 10:38am Retailer Debenhams preparing to file for administration - report
- 9:06am Niall O’Connor named as new head of Aldi Ireland
- 8:40am Rolls-Royce scraps targets, dividend on pandemic hit
- 8:40am European shares jump as coronavirus deaths slow